Search

everythinglearnresearchcommunity

for

Search:↓

The research developed methods to test drugs that could protect and restore hair follicle protection in a hair loss condition.

Immunological treatment improved both neuropathy and alopecia.

Checkpoint inhibitor therapy can cause skin issues, from mild rashes to severe reactions.

IL-3 worsens lupus nephritis and blocking it improves kidney health.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

Blocking IL-12 can help treat alopecia areata by preventing hair follicle immune issues.

IL-23 inhibitors may help treat other skin conditions, but more research is needed.

Mycophenolate mofetil can effectively treat autoimmune hepatitis when standard drugs fail.

Immunotherapy for cancer caused a patient to develop a condition affecting hormone production, requiring ongoing hormone replacement therapy.

Topical IKKα inhibitors may help prevent CCS tumours.

Psoriasis may be chronic because it lacks certain immune system controls that prevent overreaction.

Pembrolizumab can cause serious liver issues, requiring close monitoring and early treatment.

NIPP1 is important for healthy skin and could help treat skin inflammation.

Using old drugs for new uses can help treat rare immune deficiencies.

IL-1 family cytokines are crucial for skin defense and healing, but their imbalance can cause skin diseases.

Early diagnosis and targeted anti-inflammatory treatments can improve outcomes in androgenetic alopecia with perifollicular inflammation and fibrosis.

Psoriasis patients on biologic therapy have a weaker immune response to COVID-19 vaccination than healthy people.

Combining MMP-9 and JAK inhibitors can effectively prevent skin depigmentation in vitiligo.

Nail changes from immunotherapy can be managed without stopping cancer treatment.

Thiopurines help treat IBD but require genetic testing to avoid side effects.

Ruxolitinib helps protect skin stem cells and keeps skin healthy in mice with skin GVHD.

Mycophenolate mofetil is a good alternative for autoimmune hepatitis patients who can't tolerate azathioprine.

ILC1-like cells can cause alopecia areata by affecting hair follicles.

Type I interferons play a key role in the development of various skin diseases.

Tofacitinib effectively treated a woman's complex autoimmune and autoinflammatory disorders.

EGFRi/MEKi treatments cause hair follicles to lose some immune protection, leading to inflammation.

A protein called lfTSLP is important in causing allergic and other skin diseases and could be a target for treatment.

Three specific mutations in the LIPH gene can cause hair loss by damaging the protein's structure and function.

Janus kinase inhibitors show promise in treating autoimmune skin diseases.

COVID-19 infection rates were low in patients with immune diseases, regardless of their treatment type.